{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:53:19Z","timestamp":1791895999280,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.lfs.2023.122181","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T03:00:00Z","timestamp":1697511600000},"page":"122181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Drug repurposing for the identification of new Bcl-2 inhibitors: In vitro, STD-NMR, molecular docking, and dynamic simulation studies"],"prefix":"10.1016","volume":"334","author":[{"given":"Noor","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Atia-tul-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumbla","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almas","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Iqbal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2023.122181_bb0005","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/ijms22041881","article-title":"Remodeling of bone marrow niches and roles of exosomes in leukemia","volume":"22","author":"Yamaguchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.122181_bb0010","first-page":"225","article-title":"Bcl-2 and drugs used in the treatment of cancer: new strategies of biotherapy which should not be underestimated","volume":"13","author":"Berghella","year":"1998","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.lfs.2023.122181_bb0015","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2023.122181_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bmcl.2008.10.113","article-title":"Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors","volume":"19","author":"Porter","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2023.122181_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/cdd.2013.153","article-title":"The rheostat in the membrane: BCL-2 family proteins and apoptosis","volume":"21","author":"Volkmann","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2023.122181_bb0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cpt.553","article-title":"Targeting BCL2 with BH3 mimetics: basic science and clinical application of venetoclax in chronic lymphocytic leukemia and related B cell malignancies","volume":"101","author":"Roberts","year":"2017","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"key":"10.1016\/j.lfs.2023.122181_bb0035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(16)30019-5","article-title":"Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study","volume":"17","author":"Stilgenbauer","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2023.122181_bb0040","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1021\/jm300178u","article-title":"Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold","volume":"55","author":"Zhou","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122181_bb0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2023.122181_bb0050","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.374","article-title":"Protocol for apoptosis assay by flow cytometry using annexin V staining method","volume":"3","author":"Lakshmanan","year":"2013","journal-title":"Bio-protocol"},{"key":"10.1016\/j.lfs.2023.122181_bb0055","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcc.20292","article-title":"RM: integrated modeling program, applied chemical theory (IMPACT)","volume":"26","author":"Banks","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2023.122181_bb0060","first-page":"10","article-title":"Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators","author":"Aird","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.122181_bb0065","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/0008-5472.CAN-14-1849","article-title":"BH3 inhibitor sensitivity and Bcl-2 dependence in primary acute lymphoblastic leukemia cells","volume":"75","author":"Alford","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2023.122181_bb0070","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1021\/jm010016f","article-title":"Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening","volume":"44","author":"Enyedy","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122181_bb0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2019.00697","article-title":"Efficacy and safety of Bcl-2 inhibitor venetoclax in hematological malignancy: a systematic review and meta-analysis of clinical trials","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122181_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0014-2964(74)90114-5","article-title":"Clinical trial of clomiphene in advanced breast cancer","author":"Hecker","year":"1974","journal-title":"Eur. J. Cancer (1965)"},{"key":"10.1016\/j.lfs.2023.122181_bb0085","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","article-title":"Fertility treatment and cancers\u2014the eternal conundrum: a systematic review and meta-analysis","volume":"36","author":"Barcroft","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.lfs.2023.122181_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cancers11010064","article-title":"Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca2+- and p38 MAP kinase-dependent ROS generation","volume":"11","author":"Cho","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2023.122181_bb0095","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/jcmm.14011","article-title":"Anticancer activity of paroxetine in human colon cancer cells: involvement of MET and ERBB3","volume":"23","author":"Jang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2023.122181_bb0100","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2023.122181_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2015.02.015","article-title":"Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study","volume":"184","author":"Lin","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2023.122181_bb0110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1200\/jco.2005.23.16_suppl.1535","article-title":"Therapeutic potential of antidepressants in malignant glioma: clinical experience with clomipramine","volume":"23","author":"Beaney","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2023.122181_bb0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymeth.2013.03.020","article-title":"Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release","volume":"61","author":"Christensen","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.lfs.2023.122181_bb0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<338::AID-JBT8>3.0.CO;2-7","article-title":"The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation","volume":"13","author":"Xia","year":"1999","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.lfs.2023.122181_bb0125","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1021\/ed101169t","article-title":"Saturation-transfer difference (STD) NMR: a simple and fast method for ligand screening and characterization of protein binding","volume":"88","author":"Viegas","year":"2011","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.lfs.2023.122181_bb0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","article-title":"NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.lfs.2023.122181_bb0135","doi-asserted-by":"crossref","first-page":"14974","DOI":"10.1074\/jbc.RA118.003444","article-title":"Small molecule\u2013based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy","volume":"293","author":"Gervais","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122181_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jmgm.2017.11.011","article-title":"Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: a molecular dynamics simulation approach","volume":"79","author":"Wakui","year":"2018","journal-title":"J. Mol. Graph. Model."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523008160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523008160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:14:49Z","timestamp":1762211689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523008160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"alternative-id":["S0024320523008160"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122181","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing for the identification of new Bcl-2 inhibitors: In vitro, STD-NMR, molecular docking, and dynamic simulation studies","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122181"}}